FindTrial
Sign In

Population pharmacokinetics of contezolid in elderly patients

Population pharmacokinetics of contezolid in elderly patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056377
Enrollment
Unknown
Registered
2022-02-04
Start date
2022-02-15
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gram-positive bacterial infection

Interventions

Infected with Gram-positive bacteria:none

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
75 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Greater than 80 years old, male or female; 2. Patients with Gram-positive bacterial infection; 3. Patients treated with contezolid for more than 48 hours; 4. At least one steady-state plasma concentration can be obtained.

Exclusion criteria

Exclusion criteria: Patients who are intolerant to contezolid

Design outcomes

Primary

MeasureTime frame
blood drug concentration;—

Countries

China

Contacts

Public ContactCai Yun

Chinese PLA General Hospital

caicai_hh@126.com+86 10 66937166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026